US$ 29.97
employer glp-1 coverage news Among the largest employers (with at least 5,000 workers), 43% now cover GLP -1 weight-loss drugs, up from 28% last year. A majority (59%) of those same employers say their cost for the GLP-1 coverage for weight loss
Description
Personalized Care To Ensure Effective Weight Loss Results.

Glucagon-like peptide 1 (GLP-1) based therapies have seen a meteoric rise in popularity (about 300%1 increased use between 2018-2023)
How MNS Can Help Policy changes like this can create added administrative work and delays

Feel stronger

Tirzepatide targets both GLP-1 and GIP hormone receptors and is designed to support long-term weight loss as part of a personalized treatment plan.
